SCHEMBL2815813

SCHEMBL2815813

COc1ccc(/N=C(Sc2ccccc2)\C(C)=C\Oc2ccccc2OC)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 4/20 0.42
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
MAPT P10636 7/20 0.38
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
MAPK1 P28482 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NOS1 P29475 2/20 0.36
NOS2 P35228 2/20 0.36
LMNA P02545 3/20 0.34
NFKB1 P19838 2/20 0.34
CASP3 P42574 2/20 0.34
NFKB2 Q00653 2/20 0.34
RELA Q04206 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2815816 1.00 NOS3 (0.42) NOS3HTR3EHTR3BHTR3AHTR3D
SCHEMBL2816113 0.93 NOS3 (0.37) NOS3HTR3EHTR3BHTR3AHTR3D
SCHEMBL2816116 0.93 NOS3 (0.37) NOS3HTR3EHTR3BHTR3AHTR3D
SCHEMBL12851012 0.93 NOS3 (0.37) NOS3HTR3EHTR3BHTR3AHTR3D
SCHEMBL2813258 0.91 MAPT (0.41) NOS3HTR3EHTR3BHTR3AHTR3D
SCHEMBL2813255 0.91 MAPT (0.41) NOS3HTR3EHTR3BHTR3AHTR3D
SCHEMBL2808978 0.89 NOS3 (0.42) NOS3HTR3EHTR3BHTR3AHTR3D
SCHEMBL2808976 0.89 NOS3 (0.42) NOS3HTR3EHTR3BHTR3AHTR3D
SCHEMBL12850922 0.89 NOS3 (0.42) NOS3HTR3EHTR3BHTR3AHTR3D
SCHEMBL12851017 0.88 NOS3 (0.40) NOS3HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 NOS3 110/4885HTR3E 3827/4885HTR3B 4065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.